0      0

AONN+ Annual 2021 Virtual Conference

FRI04 - Industry Sponsored Session | TECENTRIQ: First FDA-Approved Adjuvant Cancer Immunotherapy in NSCLC Presented by Genentech


Nov 19, 2021 10:30am ‐ Nov 19, 2021 11:30am


Description

Presentation on the unmet need in early NSCLC, testing for PD-L1 in Stage II-IIIA NSCLC, and results from IMpower 010 study

Speaker(s):

You must be logged in and own this session in order to post comments.